Style de citation APA (7e éd.)

Christopher J. Mowry, M., Cristina Alonso, P., Marta Iruarrizaga-Lejarreta, P., Pablo Ortiz, M., Josh Levitsky, M., & Mary Rinella, M. (2021). Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer.

Style de citation Chicago (17e éd.)

Christopher J. Mowry, MD, PhD Cristina Alonso, PhD Marta Iruarrizaga-Lejarreta, MD Pablo Ortiz, MD Josh Levitsky, et MD Mary Rinella. Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer, 2021.

Style de citation MLA (8e éd.)

Christopher J. Mowry, MD, et al. Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer, 2021.